Risk Scores Boost Kidney Disease Care Adoption
Featured

Risk Scores Boost Kidney Disease Care Adoption

Gene Therapy

Risk Scores Boost Kidney Disease Care Adoption
Gene Therapy
October 24, 2026

Risk Scores Boost Kidney Disease Care Adoption

Risk scores boost kidney disease care adoption by identifying high-risk patients in electronic records and...

FDA Approves Bepirovirsen for Chronic HBV Treatment
Gene Therapy
October 22, 2026

FDA Approves Bepirovirsen for Chronic HBV Treatment

The FDA approved bepirovirsen for chronic HBV treatment, marking the first antisense oligonucleotide for this...

Breakthrough Targeted Therapies Offer Hope for Myasthenia Gravis Patients
Gene Therapy
October 21, 2026

Breakthrough Targeted Therapies Offer Hope for Myasthenia Gravis Patients

Targeted therapies are offering new hope for myasthenia gravis patients by addressing treatment gaps and...

NF Research

Read our latest NF Research articles.

Doctors Recommend Lifestyle Changes and New Medications for MASH Treatment
NF Research October 15, 2026

Doctors Recommend Lifestyle Changes and New Medications for MASH Treatment

Doctors recommend lifestyle changes and new medications for MASH treatment. Learn about this progressive liver...

The Art of the Slow Morning: Why Slower Starts Lead to Better Days
NF Research October 15, 2026

The Art of the Slow Morning: Why Slower Starts Lead to Better Days

In a culture obsessed with speed, efficiency, and instant gratification, the way we begin our...

Patient Briefs

Trial Moves

All Posts

Risk Scores Boost Kidney Disease Care Adoption
Gene Therapy

Risk Scores Boost Kidney Disease Care Adoption

Risk scores boost kidney disease care adoption by identifying high-risk patients in electronic records and providing quarterly feedback to clinicians,...

Older AML patients shift from fitness to curability in treatment
Trial Moves

Older AML patients shift from fitness to curability in treatment

Older AML patients now prioritize curability over fitness in treatment, as doctors shift focus to therapy effectiveness without excessive strain.

FDA Approves Bepirovirsen for Chronic HBV Treatment
Gene Therapy

FDA Approves Bepirovirsen for Chronic HBV Treatment

The FDA approved bepirovirsen for chronic HBV treatment, marking the first antisense oligonucleotide for this indication. It offers new hope...

Breakthrough Targeted Therapies Offer Hope for Myasthenia Gravis Patients
Gene Therapy

Breakthrough Targeted Therapies Offer Hope for Myasthenia Gravis Patients

Targeted therapies are offering new hope for myasthenia gravis patients by addressing treatment gaps and improving outcomes.

Alzheimer’s Group Aims to Improve Brain Care
Patient Briefs

Alzheimer’s Group Aims to Improve Brain Care

Alzheimer's Association aims to improve brain care with new initiative focused on dementia care and treatment.

Medicare kidney screenings rise but miss early diagnoses
Tumor Watch

Medicare kidney screenings rise but miss early diagnoses

Medicare kidney screenings rose since 2016, yet many still miss early chronic kidney disease (CKD) diagnoses despite testing increases.

New Stroke Rehab Guidelines Prioritize Early, Personalized Care
Trial Moves

New Stroke Rehab Guidelines Prioritize Early, Personalized Care

The new stroke rehabilitation guidelines urge clinicians to begin therapy within 48 hours of admission, covering physical, cognitive and mental...

FDA to Decide on Satralizumab for Thyroid Disease
NF Research

FDA to Decide on Satralizumab for Thyroid Disease

FDA to decide on satralizumab for thyroid eye disease treatment by October 15.

Doctors Recommend Lifestyle Changes and New Medications for MASH Treatment
NF Research

Doctors Recommend Lifestyle Changes and New Medications for MASH Treatment

Doctors recommend lifestyle changes and new medications for MASH treatment. Learn about this progressive liver condition and effective management strategies.

The Art of the Slow Morning: Why Slower Starts Lead to Better Days
NF Research

The Art of the Slow Morning: Why Slower Starts Lead to Better Days

In a culture obsessed with speed, efficiency, and instant gratification, the way we begin our mornings often sets the tone...

Show More →